The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2025 Annual Meeting this month in San Francisco. Researchers will discuss their findings in news briefings on Sept. 29 and 30, and complimentary meeting registration is available for credentialed press. The field's most influential scientific forum, ASTRO's Annual Meeting will feature pivotal studies in radiation medicine for patients with cancer and other diseases.

Carlos Moreno Yruela, who is currently a researcher at the Swiss Federal Institute of Technology in Lausanne, Switzerland, was selected in the ERC Starting Grants call to develop the CHEMTUBIO project at the Institute for Bioengineering of Catalonia (IBEC). The project will study the chemistry of enzymes that erase microtubule modifications. These enzymes are essential for the functioning of our cells and have shown great promise as potential therapeutic targets for treating cancer, heart disease and neurological disorders.

A new peer-reviewed study from the Environmental Working Group finds that advanced PFAS filtration systems not only remove toxic "forever chemicals" from drinking water but also significantly reduce other harmful contaminants. These include cancer-linked disinfection byproducts, agricultural nitrates, and heavy metals like arsenic and uranium. The study, published in ACS ES&T Water, analyzed data from 19 U.S. utilities and the EPA’s national monitoring program, showing that technologies like granular activated carbon, ion exchange, and reverse osmosis offer broader public health benefits than previously recognized.

When detached cancer cells squeeze through the tiniest blood vessels they can become prone to grow new tumours far from where they started, a blood flow simulation experiment suggests.